CLINICAL_TRIALS trial_result · 2021-11-24

Clinical Trial Update: COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111 [Phase 2]

Phase 2 trial update for Veru-111 in adults with severe respiratory distress syndrome related to COVID-19 has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Veru Inc. | Conditions: Respiratory Distress Syndrome, Adult | Phase 2 | Status: COMPLETED | Results posted: 2021-11-24